Jessica Grauer MA

Recommended Articles

• What is a Migraine with Aura?

  A migraine is one of the most severe headaches, and the pain often affects an individual's daily activities. A migraine headache is broadly classified into migraine without aura and migraine with aura. Migraine with aura is a less common type of headache when compared to the other migraine. Aura is...

• What Is a Pediatric Stroke: Get the Facts

  Contrary to what many people think, strokes can also occur in children, unborn babies, or infants. There are two age classifications for pediatric stroke, namely, perinatal and childhood. Childhood stroke affects infants up to 18 year-olds. Perinatal stroke refers to the last 18 weeks of gestation...

• Model Cambria Francesca's Lupus Won't Stop Her From Shining

  For fashion model Cambria Francesca, lupus has been a big part of her life and her career. A recent photo shoot snapped her showing off her figure with the word strong written across her stomach.  It was to tell the world, that her battle with the disease has made her stronger and more beautiful. ...

• What to Expect in Laminectomy and Spinal Fusion

  Decompressive laminectomy is done to release pressure exerted on the roots of the nerves found on the lower back. The condition is mostly brought by old age. There are, however, other reasons your surgeon may suggest surgery. These include herniated discs, traumas, and tumors. In case you are going...

• These Young Adults with Cystic Fibrosis Raise Awareness Through their Careers

  Treatment and management of Cystic Fibrosis (CF) has come a long way. It used to result in children dying at very early ages, but now they can live much longer and even flourish well into adulthood. This is a result of novel treatment methods, enhanced specialized care, dietary changes, and overall...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...